Related Experiment Video
Updated: Feb 12, 2026

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
Published on: January 30, 2019
Structural Insights into the Induced-fit Inhibition of Fascin by a Small-Molecule Inhibitor
Jianyun Huang1, Raja Dey1, Yufeng Wang1
1Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY 10065, United States.
Abstract:
Tumor metastasis is responsible for ~90% of all cancer deaths. One of the key steps of tumor metastasis is tumor cell migration and invasion. Filopodia are cell surface extensions that are critical for tumor cell migration. Fascin protein is the main actin-bundling protein in filopodia. Small-molecule fascin inhibitors block tumor cell migration, invasion, and metastasis. Here we present the structural basis for the mechanism of action of these small-molecule fascin inhibitors. X-ray crystal structural analysis of a complex of fascin and a fascin inhibitor shows that binding of the fascin inhibitor to the hydrophobic cleft between the domains 1 and 2 of fascin induces a ~35o rotation of domain 1, leading to the distortion of both the actin-binding sites 1 and 2 on fascin. Furthermore, the crystal structures of an inhibitor alone indicate that the conformations of the small-molecule inhibitors are dynamic. Mutations of the inhibitor-interacting residues decrease the sensitivity of fascin to the inhibitors. Our studies provide structural insights into the molecular mechanism of fascin protein function as well as the action of small-molecule fascin inhibitors.
Insights
Small-molecule fascin inhibitors block cancer metastasis by distorting fascin protein's actin-binding sites. Structural analysis reveals how these inhibitors bind, offering insights into their mechanism of action for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Tumor metastasis causes most cancer deaths, with cell migration and invasion being key steps.
- Filopodia, critical for tumor cell migration, rely on the actin-bundling protein fascin.
- Small-molecule fascin inhibitors show potential in blocking cancer spread.
Purpose of the Study:
- To elucidate the structural basis for the mechanism of action of small-molecule fascin inhibitors.
- To understand how fascin inhibitors interact with the fascin protein at a molecular level.
Main Methods:
- X-ray crystal structural analysis of fascin-inhibitor complexes.
- Analysis of inhibitor-alone crystal structures to determine conformational dynamics.
- Site-directed mutagenesis to assess the impact of specific residues on inhibitor sensitivity.
Main Results:
- Fascin inhibitor binding induces a ~35° rotation of fascin domain 1, distorting actin-binding sites.
- Small-molecule inhibitors exhibit dynamic conformations.
- Mutations in inhibitor-interacting residues reduce fascin sensitivity to inhibitors.
Conclusions:
- Structural insights reveal how fascin inhibitors disrupt fascin function.
- Understanding this mechanism can guide the development of more effective anti-metastasis drugs.
- This study provides a foundation for targeting fascin in cancer treatment.
More Related Videos
Related Concept Videos
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Feedback Inhibition
Inclusive Fitness
Goodness-of-Fit Test
Negative Regulator Molecules

